Antibodies & Hybridomas — page 16 of 30
Antibodies & Hybridomas
Page 16 of 30
| Specificity | Clone | Host Species | Reactive Species | Format | Size | Reviews | Supplier | |
|---|---|---|---|---|---|---|---|---|
| SARS-CoV-2 N Protein | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
 ORIGENE TECHNOLOGIES |
More Info |
| SARS-CoV-2 N Protein | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| SARS-CoV-2 N Protein | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| SARS-CoV-2 Spike Protein | polyclonal | Rabbit | SARS-CoV, SARS-CoV-2 | unconjugated | 100 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| SARS-CoV-2 Spike Protein | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| SARS-CoV-2 S Protein | OTI3A2 | Mouse | SARS-CoV-2 | biotin conjugate | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| SARS-CoV-2 S Protein | OTI3A2 | Mouse | SARS-CoV-2 | peroxidase (HRP) conjugate | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| SARS-CoV-2 S Protein | OTI3A2 | Mouse | SARS-CoV-2 | unconjugated | 100 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| SARS-CoV-2 S Protein | OTI3A2 | Mouse | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| SARS-CoV-2 S Protein | OTI3H6 | Mouse | SARS-CoV-2 | biotin conjugate | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| SARS-CoV-2 S Protein | OTI3H6 | Mouse | SARS-CoV-2 | peroxidase (HRP) conjugate | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| SARS-CoV-2 S Protein | OTI3H6 | Mouse | SARS-CoV-2 | unconjugated | 100 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| SARS-CoV-2 S Protein | OTI3H6 | Mouse | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| SARS-CoV-2 S Protein | OTI4C6 | Mouse | SARS-CoV-2 | biotin conjugate | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| SARS-CoV-2 S Protein | OTI4C6 | Mouse | SARS-CoV-2 | peroxidase (HRP) conjugate | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| SARS-CoV-2 S Protein | OTI4C6 | Mouse | SARS-CoV-2 | unconjugated | 100 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| SARS-CoV-2 S Protein | OTI4C6 | Mouse | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| SARS-CoV-2-ACE2 | 1A1C7 | Mouse | human | unconjugated | 100 ul | n/a |
 BIORBYT LTD. |
More Info |
| SARS-CoV-2-NSP2 | polyclonal | Rabbit | SARS-CoV-2 | affinity purified | n/a | n/a |
 ST JOHN'S LABORATORY |
More Info |
| SARS-CoV-2 NSP2 | polyclonal | n/a | n/a | unconjugated | 50 ul, 100 ul, 200 ul | n/a |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 NSP2 | polyclonal | Rabbit | n/a | unconjugated | 100 ul, 50 ul, 100 ug, 50 ug | n/a |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 NSP2 | polyclonal | Rabbit | human | unconjugated | 10 ug, 100 ug | n/a |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 S2 | monoclonal | Recombinant Human | SARS-CoV-2 | unconjugated | n/a | n/a |
 CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 (COVID-19) Spike RBD Neutralizing | C-A11 | Recombinant Rabbit | n/a | unconjugated | 200 ul | n/a |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 spike protein (RBD) neutralizing (C-A11) | CoV2-CA11 | Rabbit | n/a | unconjugated | 20 ul | n/a |
BIORBYT LTD. |
More Info |
| SARS-CoV-2/SARS-CoV Spike Protein | polyclonal | Rabbit | SARS-CoV, SARS-CoV-2 | unconjugated | 100 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| SARS-CoV-2/SARS-CoV Spike Protein | polyclonal | Rabbit | SARS-CoV, SARS-CoV-2 | unconjugated | 100 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| SARS-CoV-2 Spike (Casirivimab biosimilar) | monoclonal | Recombinant | human | Protein A/G purified, low endotoxin | 100mg | n/a |
 ICHORBIO |
More Info |
| SARS-CoV-2 Spike (Casirivimab biosimilar) | monoclonal | Recombinant | human | Protein A/G purified, low endotoxin | 10mg | n/a |
ICHORBIO |
More Info |
| SARS-CoV-2 Spike (Casirivimab biosimilar) | monoclonal | Recombinant | human | Protein A/G purified, low endotoxin | 1mg | n/a |
ICHORBIO |
More Info |
| SARS-CoV-2 Spike (Casirivimab biosimilar) | monoclonal | Recombinant | human | Protein A/G purified, low endotoxin | 20mg | n/a |
ICHORBIO |
More Info |
| SARS-CoV-2 Spike (Casirivimab biosimilar) | monoclonal | Recombinant | human | Protein A/G purified, low endotoxin | 50mg | n/a |
ICHORBIO |
More Info |
| SARS-CoV-2 Spike (Casirivimab biosimilar) | monoclonal | Recombinant | human | Protein A/G purified, low endotoxin | 5mg | n/a |
ICHORBIO |
More Info |
| SARS-CoV-2 Spike (Sotrovimab biosimilar) | monoclonal | Recombinant | human | Protein A/G purified, low endotoxin | 100mg | n/a |
ICHORBIO |
More Info |
| SARS-CoV-2 Spike (Sotrovimab biosimilar) | monoclonal | Recombinant | human | Protein A/G purified, low endotoxin | 10mg | n/a |
ICHORBIO |
More Info |
| SARS-CoV-2 Spike (Sotrovimab biosimilar) | monoclonal | Recombinant | human | Protein A/G purified, low endotoxin | 1mg | n/a |
ICHORBIO |
More Info |
| SARS-CoV-2 Spike (Sotrovimab biosimilar) | monoclonal | Recombinant | human | Protein A/G purified, low endotoxin | 20mg | n/a |
ICHORBIO |
More Info |
| SARS-CoV-2 Spike (Sotrovimab biosimilar) | monoclonal | Recombinant | human | Protein A/G purified, low endotoxin | 50mg | n/a |
ICHORBIO |
More Info |
| SARS-CoV-2 Spike (Sotrovimab biosimilar) | monoclonal | Recombinant | human | Protein A/G purified, low endotoxin | 5mg | n/a |
ICHORBIO |
More Info |
| SARS-CoV-2 3CLpro | polyclonal | n/a | n/a | unconjugated | 200 ul, 100 ul, 50 ul | n/a |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 3CLpro | polyclonal | Rabbit | n/a | unconjugated | 100 ul, 50 ul, 100 ug, 50 ug | n/a |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 NSP1 | polyclonal | n/a | n/a | unconjugated | 200 ul, 100 ul, 50 ul | n/a |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 NSP1 | polyclonal | Rabbit | n/a | unconjugated | 100 ul, 50 ul, 100 ug, 50 ug | n/a |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 NSP7 | polyclonal | n/a | n/a | unconjugated | 50 ul, 100 ul, 200 ul | n/a |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 NSP7 | polyclonal | Rabbit | n/a | unconjugated | 100 ul, 50 ul, 100 ug, 50 ug | n/a |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 NSP8 | polyclonal | n/a | n/a | unconjugated | 50 ul, 100 ul, 200 ul | n/a |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 NSP8 | polyclonal | Rabbit | n/a | unconjugated | 100 ul, 50 ul, 100 ug, 50 ug | n/a |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 Spike Protein | CV1 | Recombinant Mouse | SARS Coronavirus 2 | purified | 200 µg | n/a |
 ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike Protein | CV1 | Recombinant Human | SARS Coronavirus 2 | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike Protein | CV1 | Recombinant Human | SARS Coronavirus 2 | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike Protein | CV1 | Recombinant Ferret | SARS Coronavirus 2 | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike Protein | CV1 | Recombinant Cat | SARS Coronavirus 2 | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike Protein | CV1 | Recombinant Human | SARS Coronavirus 2 | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike Protein | CV1 | Recombinant Human | SARS Coronavirus 2 | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike Protein | CV1 | Recombinant Human | SARS Coronavirus 2 | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike Protein | CV1 | Recombinant Mouse | SARS Coronavirus 2 | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike Protein | CV1 | Recombinant Cat | SARS Coronavirus 2 | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike Protein | CV1 | Recombinant Ferret | SARS Coronavirus 2 | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | CV1 | Recombinant Mouse | SARS Coronavirus 2 | F(ab)2 fragment-His-tagged | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | CV1 | Recombinant Human | SARS Coronavirus 2 | F(ab)2 fragment-His-tagged | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | CV1 | Recombinant Mouse | SARS Coronavirus 2 | Fab fragment-His-tagged | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | CV1 | Recombinant Human | SARS Coronavirus 2 | Fab fragment-His-tagged | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | CV1 | Recombinant Ferret | SARS Coronavirus 2 | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | CV1 | Recombinant Human | SARS Coronavirus 2 | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | CV1 | Recombinant Human | SARS Coronavirus 2 | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | CV1 | Recombinant Rabbit | SARS Coronavirus 2 | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | 18F4 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | 18F4 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | 3B-D7-C2 | Recombinant Mouse | SARS Coronavirus 2 (SARS-CoV-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | 3B-D7-C2 | Recombinant Human | SARS Coronavirus 2 (SARS-CoV-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | 3B-D7-C2 | Recombinant Human | SARS Coronavirus 2 (SARS-CoV-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | 3B-G3-C6 | Recombinant Mouse | SARS Coronavirus 2 (SARS-CoV-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | 3B-G3-C6 | Recombinant Human | SARS Coronavirus 2 (SARS-CoV-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | 3B-G3-C6 | Recombinant Human | SARS Coronavirus 2 (SARS-CoV-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | 4A8 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | 4A8 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | D70678-5521-S2 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | D70678-5521-S2 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | EY6A | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | EY6A | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | MR17 | Recombinant Mouse | SARS Coronavirus 2 (SARS-Cov-2) | purified | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | MR17 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | MR17 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | MR3 | Recombinant Mouse | SARS Coronavirus 2 (SARS-Cov-2) | purified | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | MR3 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | MR3 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | Sb23 | Recombinant Mouse | SARS Coronavirus 2 (SARS-Cov-2) | purified | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | Sb23 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | Sb23 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | SR4 | Recombinant Mouse | SARS Coronavirus 2 (SARS-Cov-2) | purified | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | SR4 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | SR4 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | Ty1 | Recombinant Mouse | SARS Coronavirus 2 (SARS-Cov-2) | purified | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | Ty1 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | Ty1 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | 18F4 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | 3B-G3-C6 | Recombinant Human | SARS Coronavirus 2 (SARS-CoV-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | 4A8 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | D70678-5521-S2 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Spike protein | EY6A | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |